James D. Chalmers, MBChB, PhD
Advertisement
James Chalmers, MBChB, PhD, is Asthma and Lung UK Chair of Respiratory Medicine at the School of Medicine, University of Dundee.
Articles by James D. Chalmers, MBChB, PhD
This interview highlights the subgroup analysis findings of the ASPEN trial, specifically on brensocatib for non-cystic fibrosis bronchiectasis.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
CKM Syndrome, Artery Damage Prevalence Higher in Young Adults than Previously Believed
2
Brensocatib Patient Selection Evolves 1 Year After FDA Approval
3
ABTECT Maintenance Data Show Durable Remission in UC, With Remo Panaccione, MD
4
Why Mentorship Matters Most for Dermatology Trainees
5